A total of five TFE3 gene fusions (PRCC-TFE3, ASPSCR1-TFE3, SFPQ-TFE3, NONO-TFE3 and CLTC-TFE3) have been identified in RCC tumors and characterized at the mRNA transcript level [42]. This evidence concerns the gene PRCC and renal cell carcinoma.